What Is Gigantomastia?
Gigantomastia is a rare medical condition characterised by excessive and disproportionate growth of breast tissue. There is no universally agreed definition, but most clinical sources define it as breast hypertrophy severe enough to cause significant physical symptoms — typically involving breast weight exceeding 1–1.5kg per breast of natural tissue. It is distinct from voluntary augmentation to large volumes, though the physical challenges can overlap.
Types and Causes
Gestational gigantomastia occurs during pregnancy, driven by exaggerated breast tissue sensitivity to the hormonal changes of pregnancy — particularly elevated levels of oestrogen, progesterone, and prolactin. It can cause rapid, dramatic breast enlargement that may compress surrounding structures. Pubertal gigantomastia (virginal hypertrophy) occurs during adolescence and may continue to progress without intervention. Drug-induced gigantomastia has been documented with D-penicillamine, bucillamine, and some neuroleptics. Idiopathic gigantomastia has no identifiable cause.
Hormonal Mechanisms
The underlying mechanism in most cases appears to involve abnormal tissue sensitivity to circulating hormones rather than abnormal hormone levels themselves. Oestrogen receptor overexpression in breast tissue has been documented in some cases. Anti-oestrogen medications (tamoxifen, danazol) have been used with variable success to slow or halt progression in non-surgical cases.
Physical Effects
Gigantomastia causes a predictable set of physical problems: severe neck, back, and shoulder pain; skin ulceration and intertrigo in the inframammary fold; breathing difficulty (in severe cases, from mechanical chest compression); nerve compression; difficulty with daily activities and exercise; and significant psychological burden.
Treatment
Definitive treatment is surgical: breast reduction (typically bilateral reduction mammaplasty, sometimes total mastectomy in the most severe cases). Medical management with anti-hormonal agents may be used pre-operatively to reduce further growth. Post-surgery recurrence is documented and requires monitoring.
